Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Corbus Pharma Cmn (CRBP)

6.35 +0.40 (+6.72%)

6/23/2017  4:00pm

Open:

5.95

Pre. Close:

5.95

High:

6.38

Low:

5.85

Volume:

5,450,810

Market Cap:

318.88M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.5 - 6.71

6.71 - 6.91

Low:

5.42 - 5.58

5.58 - 5.74

Close:

6.04 - 6.36

6.36 - 6.69

Technical analysis  (as of: 2017-06-23 4:33:23 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 8.23     One year: 9.62

Support:

Support1: 6.15    Support2: 5.60

Resistance:

Resistance1: 7.05    Resistance2: 8.23

Pivot:

6.24

Moving Averages:

MA(5): 6.08     MA(20): 6.30

MA(100): 7.39     MA(250): 6.55

MACD:

MACD(12,26): -0.16     Signal(12,26,9): -0.17

%K %D:

%K(14,3): 33.33     %D(3): 30.65

RSI:

RSI(14): 50.68

52-Week:

High: 10.78  Low: 2.68  Change(%): 111.0

Average Vol(K):

3-Month: 948  10-Days 896

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CRBP has closed below upper band by 42.8%. Bollinger Bands are 16.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 23 Jun 2017 16:18:45 GMT
Corbus Pharmaceuticals Can Hit New Highs By Year's End

Thu, 30 Mar 2017 17:03:45 GMT
Why "Positive" Data Knocked Down Corbus Pharmaceuticals Holdings Inc Today

Mon, 14 Nov 2016 18:05:07 GMT
Why Corbus Pharmaceuticals Holdings Inc. Skyrocketed Higher Today

Wed, 19 Oct 2016 20:15:00 GMT
Why Corbus Pharmaceuticals Holdings Inc Jumped Higher Today

Wed, 16 Nov 2016 16:05:39 GMT
Corbus Pharmaceuticals: Past And Present

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

50.22

Shares Float (M)

41.86

% Held by Insiders

24.31

% Held by Institutions

8.40

Shares Short (K)

6680

Shares Short Prior Month (K)

6620

Stock Financials

EPS

-0.570

EPS Est. Current Year

-0.770

EPS Est. Next Year

-0.660

EPS Est. Next Quarter

-0.200

Forward EPS

-0.660

Book Value (p.s.)

0.870

PEG Ratio

Profit Margin

Operating Margin

-874.14

Return on Assets (ttm)

-50.2

Return on Equity (ttm)

-98.3

Qtrly Rev. Growth

226.2

Gross Profit (p.s.)

0.038

Sales Per Share

EBITDA (p.s.)

-0.487

Qtrly Earnings Growth

Operating Cash Flow (M)

-17.69

Levered Free Cash Flow (M)

-9.06

FoxReading.com

Valuation

P/E

-11.14

P/E Growth Ratio

0.07

P/BV

7.30

P/S

5314950144.00

P/CF

-18.03

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2017-01-03

Ex-Dividend Date

2017-11-05

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.